PLUS: The Covid-19 headlines you need to know, a distraction, and something to read.
By Eve Sneider | 08.25.22 |
|
|
Jill Biden experiences a rebound, Japan loosens travel requirements, and Dr. Fauci announces his retirement. But first, here's this week's big story: | |
Drugmakers seek FDA approval for Omicron-specific boosters This week, Moderna and Pfizer-BioNTech both asked the FDA to issue emergency use authorizations for updated Covid-19 boosters that are formulated to target Omicron, in addition to the original strain of the virus. In an interview, the top regulator at the agency said his team was close to authorizing the shots, which could make them available shortly after Labor Day. Though these formulations haven't been tested in humans, he said the data was "extremely good." Pfizer is seeking authorization for Americans 12 and up, and Moderna for all adults in the US. In the UK, Moderna's booster has already been approved for use. If approved in the US, these will be the first shots formulated to target a version of the virus other than the original strain that was identified in late 2019. Drugmakers have pointed out that while mRNA shots are theoretically easier to tailor to mutating viruses, testing and manufacturing at scale still takes time. | |
Headlines Jill Biden tested positive for Covid again yesterday, three days after exiting quarantine. Though she is experiencing a rebound case, her office reports that no symptoms have returned. (The New York Times) Japan's prime minister announced yesterday that the country will stop requiring vaccinated travelers to provide proof of a negative test before entering the country. (NPR) After leading the NIAID for nearly 40 years and serving as President Biden's chief medical adviser, Dr. Anthony Fauci has announced that he will retire in December. (The Washington Post) Starting next week, hospitals in England will no longer conduct routine Covid tests for people who are asymptomatic. Immunocompromised patients and those with symptoms will still be tested regularly. (The Guardian) Two weeks after its leader declared victory over Covid-19, North Korea has reported four new cases of a "malignant virus," one of its pseudonyms for SARS-CoV-2. (Al Jazeera) | |
|
|
|
0 Comments:
Post a Comment